Life Scientist > Biotechnology

Biota names new CEO

20 June, 2002 by Tanya Hollis

Infection and inflammation drug developer Biota Holdings has named Peter Molloy as its new chief executive, replacing Dr Hugh Niall who is retiring this year.


Agriculture, environment feature in CRC applications

19 June, 2002 by Iain Scott

Applications focusing on agriculture, the environment and medical research feature highly in the latest round of applications for funding under the Cooperative Research Centre (CRC) program.


Cultivating hairy roots for herbal medicine

19 June, 2002 by Melissa Trudinger

A new technology for growing plant tissues in fermentation tanks may allow large-scale production of the bioactive components of herbal medicines like Echinacea, ginseng and Gynostemma.


Ozgene in US deal to advance its GE rodent program

19 June, 2002 by Tanya Hollis

An Australian company will soon be offering genetically altered rodents modified at the single-cell stage to maximise efficiencies.


Amphibian adhesive may have wound appliations

19 June, 2002 by Melissa Trudinger

Scientists at the University of Adelaide and CSIRO Molecular Science are investigating a novel 'glue' from frogs, which could have applications as a bioadhesive for surgical wounds.


CSL blood supply contract renewed

19 June, 2002 by Melissa Trudinger

The Federal government has renewed its contract with CSL to supply blood to blood banks and pathology labs for use in diagnostic procedures.


Environmental biotech: Innovative research environment

18 June, 2002 by Melissa Trudinger

In the first two rounds of Biotechnology Innovation Fund (BIF) grants, five companies with a clearly environmental slant obtained funding. In the first round, these included Pestat, which is commercialising immunocontraceptive mechanisms developed by the CRC for biological control of pest animals, and Orica Australia, which is developing enzyme-based methods for pesticide degradation.


Environmental biotech: Bugs and biotechnology

18 June, 2002 by Melissa Trudinger

With alarm bells ringing over genetically modified organisms and their potential effects on the environment, stories about how biotechnology is also being used to improve the environment are harder to find.


Top-seeded research

18 June, 2002 by Pete Young

Queensland research is cutting the time and cost of seed line improvements by using DNA markers to identify high-yielding sunflower seeds.


Cerylid seals US Anadys deal

18 June, 2002 by Tanya Hollis

Private drug discovery and genomics company Cerylid Biosciences has clinched a deal with Anadys Pharmaceuticals in the United States to search for new anti-infective compounds.


Sheep genomics program proposed

18 June, 2002 by Melissa Trudinger

In a new approach to animal science, Meat and Livestock Australia (MLA) is meeting with scientists with a wide range of experience in medical and animal sciences to establish a functional genomics program for the sheep industry.


Panbio celebrates first FDA approval

17 June, 2002 by Melissa Trudinger

In a first for the company, Panbio's diagnostic panel for glandular fever has been approved by the US Food and Drug Administration (FDA).


How hairy-nosed DNA could save a northerner from extinction

17 June, 2002 by Claire Doble

DNA testing could be the key to preventing the northern hairy-nosed wombat from becoming extinct.


WA govt waits to be convinced on GM benefits

17 June, 2002 by Pete Young

The Western Australian government is approaching zero hour on the issue of whether to ban genetically-modified (GM) commercial food crops, says Agriculture Minister Kim Chance.


SDI champing at the bit for projected profit jump

14 June, 2002 by Tanya Hollis

Dental materials manufacturer SDI is tracking for a 40 per cent full-year profit jump on the back of the company's R&D investment and push into global markets.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd